Sun Pharma’s arm gets preliminary injunctive relief Prohibiting Biofrontera

27 Dec 2018 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG from using DUSA's confidential and proprietary trade secret information.

Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1777.65 2.45 (0.14%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.